PE20030978A1 - METABOLITES OF (3 - {[4-TERC-BUTYLBENZYL) - (PYRIDIN-3-SULFONYL) -AMINO] -METIL} -PHENOXY) -ACETIC ACID - Google Patents
METABOLITES OF (3 - {[4-TERC-BUTYLBENZYL) - (PYRIDIN-3-SULFONYL) -AMINO] -METIL} -PHENOXY) -ACETIC ACIDInfo
- Publication number
- PE20030978A1 PE20030978A1 PE2003000086A PE2003000086A PE20030978A1 PE 20030978 A1 PE20030978 A1 PE 20030978A1 PE 2003000086 A PE2003000086 A PE 2003000086A PE 2003000086 A PE2003000086 A PE 2003000086A PE 20030978 A1 PE20030978 A1 PE 20030978A1
- Authority
- PE
- Peru
- Prior art keywords
- pyridin
- amino
- phenoxy
- methyl
- terc
- Prior art date
Links
- -1 PYRIDIN-3-SULFONYL Chemical class 0.000 title abstract 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 title abstract 4
- 239000002207 metabolite Substances 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 3
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
- C07D213/71—Sulfur atoms to which a second hetero atom is attached
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
SE REFIERE A COMPUESTOS COMO ACIDO 2-(4-{[(3-CARBOXIMETOXIBENCIL)-(PIRIDIN-3-SULFONIL)-AMINO]-METIL} FENIL)-2-METILPROPIONICO, ACIDO (3-{[(4-(2-HIDROXI-1,1-DIMETILETIL)BENCIL)-(PIRIDIN-3-SULFONIL)AMINO]METIL} FENOXI)ACETICO, ACIDO (3-{[(4-TERC-BUTILBENCIL)-(PIRIDIN-N-OXIDO-3-SULFONIL)-AMINO]-METIL} FENOXI)-ACETICO. ACIDO (5-{[(4-TERC-BUTILBENCIL)-(PIRIDIN-3-SULFONIL)-AMINO]-METIL} HIDROXIFENOXI)ACETICO. SE REFIERE TAMBIEN AL COMPUESTO ACIDO 2-{4-[PIRIDIN-N-OXIDO-3-SULFONILAMINO)METIL]FENIL}-2-METIL-PROPIONICO, GLUCORONICO DEL ACIDO (3-{[(4-(2-HIDROXI-1,1-DIMETILETIL)BENCIL)-(PIRIDIN-3-SULFONIL)AMINO]METIL} FENOXI)ACETICO, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA UTIL EN EL TRATAMIENTO DE OSTEOPOROSISREFERS TO COMPOUNDS SUCH AS 2- (4 - {[(3-CARBOXIMETOXIBENZYL) - (PYRIDIN-3-SULFONYL) -AMINO] -MEthyl} PHENYL) -2-METHYLPROPIONIC ACID, (3 - {[(4- (2 -HYDROXY-1,1-DIMETHYLETHYL) BENZYL) - (PYRIDIN-3-SULFONIL) AMINO] METHYL} PHENOXY) ACETIC, ACID (3 - {[(4-TERC-BUTYLBENZYL) - (PYRIDIN-N-OXIDO-3- SULFONIL) -AMINO] -METIL} PHENOXY) -ACETICO. (5 - {[(4-TERC-BUTYLBENZYL) - (PYRIDIN-3-SULFONYL) -AMINO] -METHYL} HYDROXYPHENOXY) ACETIC ACID. ALSO REFERS TO THE ACID COMPOUND 2- {4- [PYRIDIN-N-OXIDO-3-SULFONYLAMINO) METHYL] PHENYL} -2-METHYL-PROPIONIC, GLUCORONIC ACID (3 - {[(4- (2-HYDROXY-1 , 1-DIMETHYLETHYL) BENZYL) - (PYRIDIN-3-SULFONIL) AMINO] METHYL} PHENOXY) ACETIC, AMONG OTHERS. ALSO REFERS TO A USEFUL PHARMACEUTICAL COMPOSITION IN THE TREATMENT OF OSTEOPOROSIS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35374802P | 2002-01-31 | 2002-01-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20030978A1 true PE20030978A1 (en) | 2003-11-19 |
Family
ID=27663249
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2003000086A PE20030978A1 (en) | 2002-01-31 | 2003-01-28 | METABOLITES OF (3 - {[4-TERC-BUTYLBENZYL) - (PYRIDIN-3-SULFONYL) -AMINO] -METIL} -PHENOXY) -ACETIC ACID |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US6852863B2 (en) |
| EP (1) | EP1470109A1 (en) |
| JP (1) | JP2005521668A (en) |
| KR (1) | KR20040077884A (en) |
| CN (1) | CN1625549A (en) |
| AP (1) | AP2004003094A0 (en) |
| AR (1) | AR038332A1 (en) |
| BR (1) | BR0307339A (en) |
| CA (1) | CA2473984A1 (en) |
| EA (1) | EA200400724A1 (en) |
| EC (1) | ECSP045215A (en) |
| GB (1) | GB2400100B (en) |
| HN (1) | HN2003000051A (en) |
| HR (1) | HRP20040683A2 (en) |
| HU (1) | HUP0500012A2 (en) |
| IL (1) | IL162167A0 (en) |
| IS (1) | IS7281A (en) |
| MA (1) | MA27169A1 (en) |
| MX (1) | MXPA04004960A (en) |
| NO (1) | NO20043569D0 (en) |
| OA (1) | OA12760A (en) |
| PA (1) | PA8564601A1 (en) |
| PE (1) | PE20030978A1 (en) |
| PL (1) | PL371982A1 (en) |
| TN (1) | TNSN04138A1 (en) |
| TW (1) | TW200302080A (en) |
| UY (1) | UY27632A1 (en) |
| WO (1) | WO2003064391A1 (en) |
| ZA (1) | ZA200404067B (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA67754C2 (en) * | 1997-10-10 | 2004-07-15 | Пфайзер, Інк. | Prostaglandin agonists and use thereof for the treatment of bone disorders |
| US7666330B2 (en) * | 2005-04-20 | 2010-02-23 | Lg Chem, Ltd. | Additive for non-aqueous electrolyte and secondary battery using the same |
| AU2007280130B2 (en) * | 2006-07-28 | 2011-09-22 | Pfizer Products Inc. | EP2 agonists |
| EP2126574B1 (en) | 2007-03-08 | 2015-12-23 | The Board of Trustees of the Leland Stanford Junior University | Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof |
| EP2002834A1 (en) * | 2007-06-13 | 2008-12-17 | Bayer Schering Pharma Aktiengesellschaft | Aryl and hetaryl amides as modulators of EP2 receptors |
| PT2264009T (en) * | 2008-03-12 | 2019-04-29 | Ube Industries | Pyridylaminoacetic acid compound |
| EP2149552A1 (en) | 2008-07-30 | 2010-02-03 | Bayer Schering Pharma AG | 5,6 substituted benzamide derivatives as modulators of EP2 receptors |
| EP2149554A1 (en) | 2008-07-30 | 2010-02-03 | Bayer Schering Pharma Aktiengesellschaft | Indolyamides as modulators for an EP2 receptor |
| EP2149551A1 (en) | 2008-07-30 | 2010-02-03 | Bayer Schering Pharma AG | N-(indol-3-ylalkyl)-(hetero)arylamid derivatives as modulators of EP2 receptors |
| US8354435B2 (en) | 2008-09-08 | 2013-01-15 | The Board Of Trustees Of The Leland Stanford Junior University | Modulators of aldehyde dehydrogenase activity and methods of use thereof |
| US8389522B2 (en) | 2008-10-28 | 2013-03-05 | The Board Of Trustees Of The Leland Stanford Junior University | Modulators of aldehyde dehydrogenase and methods of use thereof |
| PL2415763T3 (en) | 2009-03-30 | 2016-05-31 | Ube Industries | Pharmaceutical composition for treating or preventing glaucoma |
| DE102009049662A1 (en) | 2009-10-13 | 2011-04-14 | Bayer Schering Pharma Aktiengesellschaft | 2,5-disubstituted 2H-indazoles as EP2 receptor antagonists |
| WO2012149106A1 (en) | 2011-04-29 | 2012-11-01 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for increasing proliferation of adult salivary stem cells |
| TW201326154A (en) | 2011-11-28 | 2013-07-01 | 拜耳知識產權公司 | Novel 2H-indazoles as EP2 receptor antagonists |
| US9670162B2 (en) | 2013-03-14 | 2017-06-06 | The Board Of Trustees Of The Leland Stanford Junio | Mitochondrial aldehyde dehyrogenase-2 modulators and methods of use thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA67754C2 (en) * | 1997-10-10 | 2004-07-15 | Пфайзер, Інк. | Prostaglandin agonists and use thereof for the treatment of bone disorders |
-
2003
- 2003-01-20 JP JP2003564014A patent/JP2005521668A/en active Pending
- 2003-01-20 GB GB0413967A patent/GB2400100B/en not_active Expired - Fee Related
- 2003-01-20 HU HU0500012A patent/HUP0500012A2/en unknown
- 2003-01-20 BR BR0307339-4A patent/BR0307339A/en not_active IP Right Cessation
- 2003-01-20 CN CNA038029952A patent/CN1625549A/en active Pending
- 2003-01-20 KR KR10-2004-7011618A patent/KR20040077884A/en not_active Application Discontinuation
- 2003-01-20 MX MXPA04004960A patent/MXPA04004960A/en unknown
- 2003-01-20 IL IL16216703A patent/IL162167A0/en unknown
- 2003-01-20 EP EP03700072A patent/EP1470109A1/en not_active Withdrawn
- 2003-01-20 WO PCT/IB2003/000121 patent/WO2003064391A1/en active Application Filing
- 2003-01-20 AP APAP/P/2004/003094A patent/AP2004003094A0/en unknown
- 2003-01-20 PL PL03371982A patent/PL371982A1/en not_active Application Discontinuation
- 2003-01-20 CA CA002473984A patent/CA2473984A1/en not_active Abandoned
- 2003-01-20 EA EA200400724A patent/EA200400724A1/en unknown
- 2003-01-20 OA OA1200400198A patent/OA12760A/en unknown
- 2003-01-24 TW TW092101619A patent/TW200302080A/en unknown
- 2003-01-28 HN HN2003000051A patent/HN2003000051A/en unknown
- 2003-01-28 PE PE2003000086A patent/PE20030978A1/en not_active Application Discontinuation
- 2003-01-29 US US10/353,671 patent/US6852863B2/en not_active Expired - Fee Related
- 2003-01-29 AR ARP030100254A patent/AR038332A1/en unknown
- 2003-01-30 PA PA20038564601A patent/PA8564601A1/en unknown
- 2003-01-30 UY UY27632A patent/UY27632A1/en not_active Application Discontinuation
-
2004
- 2004-05-21 IS IS7281A patent/IS7281A/en unknown
- 2004-05-25 ZA ZA200404067A patent/ZA200404067B/en unknown
- 2004-07-21 MA MA27796A patent/MA27169A1/en unknown
- 2004-07-23 HR HR20040683A patent/HRP20040683A2/en not_active Application Discontinuation
- 2004-07-27 TN TNP2004000138A patent/TNSN04138A1/en unknown
- 2004-07-30 EC EC2004005215A patent/ECSP045215A/en unknown
- 2004-08-26 NO NO20043569A patent/NO20043569D0/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1625549A (en) | 2005-06-08 |
| KR20040077884A (en) | 2004-09-07 |
| WO2003064391A1 (en) | 2003-08-07 |
| IL162167A0 (en) | 2005-11-20 |
| EA200400724A1 (en) | 2004-12-30 |
| TNSN04138A1 (en) | 2007-03-12 |
| MXPA04004960A (en) | 2005-04-08 |
| AR038332A1 (en) | 2005-01-12 |
| JP2005521668A (en) | 2005-07-21 |
| US6852863B2 (en) | 2005-02-08 |
| PA8564601A1 (en) | 2003-09-05 |
| TW200302080A (en) | 2003-08-01 |
| PL371982A1 (en) | 2005-07-11 |
| GB2400100A (en) | 2004-10-06 |
| GB2400100B (en) | 2006-04-12 |
| US20030216445A1 (en) | 2003-11-20 |
| CA2473984A1 (en) | 2003-08-07 |
| OA12760A (en) | 2006-07-04 |
| EP1470109A1 (en) | 2004-10-27 |
| BR0307339A (en) | 2004-12-07 |
| MA27169A1 (en) | 2005-01-03 |
| NO20043569L (en) | 2004-08-26 |
| AP2004003094A0 (en) | 2004-09-30 |
| IS7281A (en) | 2004-05-21 |
| ECSP045215A (en) | 2004-09-28 |
| HUP0500012A2 (en) | 2005-04-28 |
| UY27632A1 (en) | 2003-08-29 |
| GB0413967D0 (en) | 2004-07-28 |
| HN2003000051A (en) | 2003-09-24 |
| ZA200404067B (en) | 2005-08-29 |
| HRP20040683A2 (en) | 2004-10-31 |
| NO20043569D0 (en) | 2004-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20030978A1 (en) | METABOLITES OF (3 - {[4-TERC-BUTYLBENZYL) - (PYRIDIN-3-SULFONYL) -AMINO] -METIL} -PHENOXY) -ACETIC ACID | |
| NO20061420L (en) | 3 - [(2- (4-Hexyloxycarbonylamino-imino-methyl) -phenylamino] -methyl} -1-methyl-1H-benzimidazole-5-carbonyl) -pyridin-2-yl-amino] -propanoic acid Ethyl ester Methanesulfonate and | |
| PE20081120A1 (en) | HYDANTOIN DERIVATIVES AS INHIBITORS OF MATRIX METALOPROTEINASES (MMP) | |
| TW200716610A (en) | Physiologically acceptable salts of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester | |
| PE20040516A1 (en) | DERIVATIVES OF 1,2-AZOL | |
| PE20120812A1 (en) | VINYL INDAZOLYL COMPOUNDS | |
| NZ601786A (en) | Novel compounds and compositions and methods of use | |
| EP2529624A3 (en) | Substituted benzene fungicides | |
| AR054278A1 (en) | POLYMORPHIC FORMS OF ETHYL ESTER OF ACID 3 - ((2- {(4- (HEXILOXICARBONILAMINO- IMINO-METTIL) - PHENYLAMINE) -METIL} -1-METHYL-H-BENCIMIDAZOL-5- CARBONIL) PIRIDIN-2-IL-AMINO ) -PROPIONIC | |
| PE20091002A1 (en) | DIPEPTIDED ANALOGS AS INHIBITORS OF THE COAGULATION FACTOR | |
| EP2578574A4 (en) | Optically active dibenzylamine derivative, and manufacturing method for same | |
| UA92354C2 (en) | Amino acid salts of rosiglitazone | |
| RU2010150911A (en) | AMIDE COMPOUND | |
| PE20060298A1 (en) | BENZHIMIDAZOLONE CARBOXYL ACID DERIVATIVES | |
| EA200801507A1 (en) | OPTICALLY ACTIVE CARBAMATES, METHOD OF THEIR PRODUCTION AND THEIR APPLICATION AS PHARMACEUTICAL INTERMEDIATE COMPOUNDS | |
| DK1701722T3 (en) | N-Hydroxy-4- {5- [4- (5-isopropyl-2-methyl-1,3-thiazol-4-yl) phenoxy] pentoxy} benzamidine-2-methanesulfonic acid salt | |
| PE20121732A1 (en) | SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS USEFUL INHIBITORS OF HSL IN THE TREATMENT OF DIABETES | |
| NZ600017A (en) | 5-hydroxypyrimidine-4-carboxamide derivative | |
| WO2009041705A3 (en) | 5-membered heterocyclic compounds as proton pump inhibitors | |
| WO2007096889A3 (en) | Process for preparing montelukast and salts thereof | |
| NO20060379L (en) | The polymorphic form of 4- [6-acetyl-3- [3- (4-acetyl-3-hydroxy-2-propylphenylthio) propoxy] -2-propylphenoxybutanoic acid | |
| NO20074303L (en) | 7- {4- [2- (2,6-dichloro-4-methylphenoxy) ethoxy] phenyl} -3,9-diazabicyclo [3.3.1] non-6-ene-6-karboksylsyresyklopropyl- (2,3- dimethylbenzyl) amide as a renin inhibitor for the treatment of hypertension | |
| PE20090243A1 (en) | IMIDAZOLE COMPOUNDS SUBSTITUTED AS RENIN INHIBITORS | |
| PE20110433A1 (en) | ANTAGONISTS OF THE DISUSTITUTED PHTHALAZINE HEDGEHOG PATHWAY | |
| PE20210859A1 (en) | TRIAZOL GLYCOLATE OXIDASE INHIBITORS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |